Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Shiladitya Sengupta, Ph.D.

Title
Institution
Department
Address
Phone
Other Positions
Title
Institution
Department

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R01CA236702 (SENGUPTA, SHILADITYA) Apr 1, 2019 - Mar 31, 2024
    NIH/NCI
    Whitlockite nanoparticle-based immunotherapy for bone metastasis
    Role: Principal Investigator
  2. U01CA214411 (SENGUPTA, SHILADITYA) Sep 21, 2017 - Jul 31, 2022
    NIH/NCI
    Engineering personalized micro-tumor ecosystems
    Role: Co-Principal Investigator
  3. R21CA186009 (SENGUPTA, SHILADITYA) May 16, 2014 - Apr 30, 2016
    NIH/NCI
    Engineering a supramolecular platinum nanoparticle for pediatric cancer
    Role: Principal Investigator
  4. R01CA135242 (SENGUPTA, SHILADITYA) Mar 19, 2010 - Dec 31, 2014
    NIH/NCI
    Multifunctional nanoparticles for targeting aberrant tumorigenic pathways
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Gupta N, Ansari A, Dhoke GV, Chilamari M, Sivaccumar J, Kumari S, Chatterjee S, Goyal R, Dutta PK, Samarla M, Mukherjee M, Sarkar A, Mandal SK, Rai V, Biswas G, Sengupta A, Roy S, Roy M, Sengupta S. Author Correction: Computationally designed antibody-drug conjugates self-assembled via affinity ligands. Nat Biomed Eng. 2020 Jan; 4(1):131. PMID: 31900467.
    Citations:    
  2. Gupta N, Ansari A, Dhoke GV, Chilamari M, Sivaccumar J, Kumari S, Chatterjee S, Goyal R, Dutta PK, Samarla M, Mukherjee M, Sarkar A, Mandal SK, Rai V, Biswas G, Sengupta A, Roy S, Roy M, Sengupta S. Computationally designed antibody-drug conjugates self-assembled via affinity ligands. Nat Biomed Eng. 2019 11; 3(11):917-929. PMID: 31686001.
    Citations:    
  3. Goldman A, Khiste S, Freinkman E, Dhawan A, Majumder B, Mondal J, Pinkerton AB, Eton E, Medhi R, Chandrasekar V, Rahman MM, Ichimura T, Gopinath KS, Majumder P, Kohandel M, Sengupta S. Targeting tumor phenotypic plasticity and metabolic remodeling in adaptive cross-drug tolerance. Sci Signal. 2019 08 20; 12(595). PMID: 31431543.
    Citations:    
  4. Jang HL, Sengupta S. Transcellular transfer of nanomedicine. Nat Nanotechnol. 2019 08; 14(8):731-732. PMID: 31263193.
    Citations:    
  5. Connor Y, Tekleab Y, Tekleab S, Nandakumar S, Bharat D, Sengupta S. A mathematical model of tumor-endothelial interactions in a 3D co-culture. Sci Rep. 2019 06 10; 9(1):8429. PMID: 31182723.
    Citations:    
  6. Kulkarni A, Chandrasekar V, Natarajan SK, Ramesh A, Pandey P, Nirgud J, Bhatnagar H, Ashok D, Ajay AK, Sengupta S. A designer self-assembled supramolecule amplifies macrophage immune responses against aggressive cancer. Nat Biomed Eng. 2018 08; 2(8):589-599. PMID: 30956894.
    Citations:    
  7. Sengupta S, Yang C, Hegde ML, Hegde PM, Mitra J, Pandey A, Dutta A, Datarwala AT, Bhakat KK, Mitra S. Acetylation of oxidized base repair-initiating NEIL1 DNA glycosylase required for chromatin-bound repair complex formation in the human genome increases cellular resistance to oxidative stress. DNA Repair (Amst). 2018 Jun - Jul; 66-67:1-10. PMID: 29698889.
    Citations:    Fields:    Translation:HumansCells
  8. Ghosh S, Sinha M, Bhattacharyya A, Sadhasivam S, Megha J, Reddy S, Saini S, Singh H, Kumar D, Kaur SP, Mishra M, Usharani D, Ghosh S, Sengupta S. A Rationally Designed Multifunctional Antibiotic for the Treatment of Drug-Resistant Acne. J Invest Dermatol. 2018 06; 138(6):1400-1408. PMID: 29409921.
    Citations:    Fields:    
  9. Sengupta S. Cancer Nanomedicine: Lessons for Immuno-Oncology. Trends Cancer. 2017 08; 3(8):551-560. PMID: 28780932.
    Citations: 1     Fields:    Translation:Humans
  10. Gupta N, Kancharla J, Kaushik S, Ansari A, Hossain S, Goyal R, Pandey M, Sivaccumar J, Hussain S, Sarkar A, Sengupta A, Mandal SK, Roy M, Sengupta S. Development of a facile antibody-drug conjugate platform for increased stability and homogeneity. Chem Sci. 2017 Mar 01; 8(3):2387-2395. PMID: 28451344.
    Citations: 1     
  11. Calibasi Kocal G, Güven S, Foygel K, Goldman A, Chen P, Sengupta S, Paulmurugan R, Baskin Y, Demirci U. Dynamic Microenvironment Induces Phenotypic Plasticity of Esophageal Cancer Cells Under Flow. Sci Rep. 2016 12 02; 6:38221. PMID: 27910892.
    Citations: 2     Fields:    Translation:HumansCells
  12. Kulkarni A, Natarajan SK, Chandrasekar V, Pandey PR, Sengupta S. Combining Immune Checkpoint Inhibitors and Kinase-Inhibiting Supramolecular Therapeutics for Enhanced Anticancer Efficacy. ACS Nano. 2016 Oct 25; 10(10):9227-9242. PMID: 27656909.
    Citations: 2     Fields:    
  13. Kulkarni A, Pandey P, Rao P, Mahmoud A, Goldman A, Sabbisetti V, Parcha S, Natarajan SK, Chandrasekar V, Dinulescu D, Roy S, Sengupta S. Algorithm for Designing Nanoscale Supramolecular Therapeutics with Increased Anticancer Efficacy. ACS Nano. 2016 09 27; 10(9):8154-68. PMID: 27452234.
    Citations: 1     Fields:    Translation:Cells
  14. Goldman A, Kulkarni A, Kohandel M, Pandey P, Rao P, Natarajan SK, Sabbisetti V, Sengupta S. Rationally Designed 2-in-1 Nanoparticles Can Overcome Adaptive Resistance in Cancer. ACS Nano. 2016 06 28; 10(6):5823-34. PMID: 27257911.
    Citations: 5     Fields:    
  15. Molavian HR, Goldman A, Phipps CJ, Kohandel M, Wouters BG, Sengupta S, Sivaloganathan S. Drug-induced reactive oxygen species (ROS) rely on cell membrane properties to exert anticancer effects. Sci Rep. 2016 06 09; 6:27439. PMID: 27278439.
    Citations:    Fields:    Translation:HumansCells
  16. Boareto M, Jolly MK, Goldman A, Pietilä M, Mani SA, Sengupta S, Ben-Jacob E, Levine H, Onuchic JN. Notch-Jagged signalling can give rise to clusters of cells exhibiting a hybrid epithelial/mesenchymal phenotype. J R Soc Interface. 2016 05; 13(118). PMID: 27170649.
    Citations: 12     Fields:    Translation:HumansCells
  17. Bhakat KK, Sengupta S, Adeniyi VF, Roychoudhury S, Nath S, Bellot LJ, Feng D, Mantha AK, Sinha M, Qiu S, Luxon BA. Regulation of limited N-terminal proteolysis of APE1 in tumor via acetylation and its role in cell proliferation. Oncotarget. 2016 Apr 19; 7(16):22590-604. PMID: 26981776.
    Citations: 7     Fields:    Translation:HumansCells
  18. Kulkarni AA, Vijaykumar VE, Natarajan SK, Sengupta S, Sabbisetti VS. Sustained inhibition of cMET-VEGFR2 signaling using liposome-mediated delivery increases efficacy and reduces toxicity in kidney cancer. Nanomedicine. 2016 10; 12(7):1853-1861. PMID: 27084552.
    Citations: 3     Fields:    Translation:HumansCells
  19. Kulkarni A, Rao P, Natarajan S, Goldman A, Sabbisetti VS, Khater Y, Korimerla N, Chandrasekar V, Mashelkar RA, Sengupta S. Reporter nanoparticle that monitors its anticancer efficacy in real time. Proc Natl Acad Sci U S A. 2016 Apr 12; 113(15):E2104-13. PMID: 27036008.
    Citations: 5     Fields:    Translation:HumansAnimalsCells
  20. Connor Y, Tekleab S, Nandakumar S, Walls C, Tekleab Y, Husain A, Gadish O, Sabbisetti V, Kaushik S, Sehrawat S, Kulkarni A, Dvorak H, Zetter B, R Edelman E, Sengupta S. Physical nanoscale conduit-mediated communication between tumour cells and the endothelium modulates endothelial phenotype. Nat Commun. 2015 Dec 16; 6:8671. PMID: 26669454.
    Citations: 10     Fields:    Translation:HumansCells
  21. Nandi MK, Banerjee A, Sengupta S, Sastry S, Bhattacharyya SM. Unraveling the success and failure of mode coupling theory from consideration of entropy. J Chem Phys. 2015 Nov 07; 143(17):174504. PMID: 26547173.
    Citations:    Fields:    
  22. Majumder B, Baraneedharan U, Thiyagarajan S, Radhakrishnan P, Narasimhan H, Dhandapani M, Brijwani N, Pinto DD, Prasath A, Shanthappa BU, Thayakumar A, Surendran R, Babu GK, Shenoy AM, Kuriakose MA, Bergthold G, Horowitz P, Loda M, Beroukhim R, Agarwal S, Sengupta S, Sundaram M, Majumder PK. Predicting clinical response to anticancer drugs using an ex vivo platform that captures tumour heterogeneity. Nat Commun. 2015 Feb 27; 6:6169. PMID: 25721094.
    Citations: 32     Fields:    Translation:Humans
  23. Goldman A, Majumder B, Dhawan A, Ravi S, Goldman D, Kohandel M, Majumder PK, Sengupta S. Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transition. Nat Commun. 2015 Feb 11; 6:6139. PMID: 25669750.
    Citations: 39     Fields:    Translation:HumansAnimalsCells
  24. Banerjee A, Sengupta S, Sastry S, Bhattacharyya SM. Role of Structure and Entropy in Determining Differences in Dynamics for Glass Formers with Different Interaction Potentials. Phys Rev Lett. 2014 Nov 28; 113(22):225701. PMID: 25494076.
    Citations: 3     Fields:    
  25. Pandey A, Sarangi S, Chien K, Sengupta P, Papa AL, Basu S, Sengupta S. Anti-platelet agents augment cisplatin nanoparticle cytotoxicity by enhancing tumor vasculature permeability and drug delivery. Nanotechnology. 2014 Nov 07; 25(44):445101. PMID: 25302488.
    Citations: 4     Fields:    Translation:AnimalsCells
  26. Pandey A, Kulkarni A, Roy B, Goldman A, Sarangi S, Sengupta P, Phipps C, Kopparam J, Oh M, Basu S, Kohandel M, Sengupta S. Sequential application of a cytotoxic nanoparticle and a PI3K inhibitor enhances antitumor efficacy. Cancer Res. 2014 Feb 01; 74(3):675-685. PMID: 24121494.
    Citations: 3     Fields:    Translation:HumansAnimalsCells
  27. Kulkarni AA, Roy B, Rao PS, Wyant GA, Mahmoud A, Ramachandran M, Sengupta P, Goldman A, Kotamraju VR, Basu S, Mashelkar RA, Ruoslahti E, Dinulescu DM, Sengupta S. Supramolecular nanoparticles that target phosphoinositide-3-kinase overcome insulin resistance and exert pronounced antitumor efficacy. Cancer Res. 2013 Dec 01; 73(23):6987-97. PMID: 24121488.
    Citations: 3     Fields:    Translation:HumansAnimalsCells
  28. Papa AL, Sidiqui A, Balasubramanian SU, Sarangi S, Luchette M, Sengupta S, Harfouche R. PEGylated liposomal Gemcitabine: insights into a potential breast cancer therapeutic. Cell Oncol (Dordr). 2013 Dec; 36(6):449-57. PMID: 24081907.
    Citations: 6     Fields:    Translation:HumansAnimalsCells
  29. Sengupta S, Mitra S, Bhakat KK. Dual regulatory roles of human AP-endonuclease (APE1/Ref-1) in CDKN1A/p21 expression. PLoS One. 2013; 8(7):e68467. PMID: 23874636.
    Citations: 12     Fields:    Translation:HumansCells
  30. Sengupta S, Kulkarni A. Design principles for clinical efficacy of cancer nanomedicine: a look into the basics. ACS Nano. 2013 Apr 23; 7(4):2878-82. PMID: 23607425.
    Citations: 7     Fields:    Translation:Humans
  31. Sarangi S, Pandey A, Papa AL, Sengupta P, Kopparam J, Dadwal U, Basu S, Sengupta S. P2Y12 receptor inhibition augments cytotoxic effects of cisplatin in breast cancer. Med Oncol. 2013; 30(2):567. PMID: 23568163.
    Citations: 5     Fields:    Translation:HumansAnimalsCells
  32. Papa AL, Basu S, Sengupta P, Banerjee D, Sengupta S, Harfouche R. Mechanistic studies of Gemcitabine-loaded nanoplatforms in resistant pancreatic cancer cells. BMC Cancer. 2012 Sep 22; 12:419. PMID: 22998550.
    Citations: 10     Fields:    Translation:HumansCells
  33. Sengupta P, Basu S, Soni S, Pandey A, Roy B, Oh MS, Chin KT, Paraskar AS, Sarangi S, Connor Y, Sabbisetti VS, Kopparam J, Kulkarni A, Muto K, Amarasiriwardena C, Jayawardene I, Lupoli N, Dinulescu DM, Bonventre JV, Mashelkar RA, Sengupta S. Cholesterol-tethered platinum II-based supramolecular nanoparticle increases antitumor efficacy and reduces nephrotoxicity. Proc Natl Acad Sci U S A. 2012 Jul 10; 109(28):11294-9. PMID: 22733767.
    Citations: 17     Fields:    Translation:AnimalsCells
  34. Paraskar A, Soni S, Roy B, Papa AL, Sengupta S. Rationally designed oxaliplatin-nanoparticle for enhanced antitumor efficacy. Nanotechnology. 2012 Feb 24; 23(7):075103. PMID: 22275055.
    Citations: 4     Fields:    Translation:HumansAnimalsCells
  35. Piecewicz SM, Pandey A, Roy B, Xiang SH, Zetter BR, Sengupta S. Insulin-like growth factors promote vasculogenesis in embryonic stem cells. PLoS One. 2012; 7(2):e32191. PMID: 22363814.
    Citations: 16     Fields:    Translation:AnimalsCells
  36. Roy RS, Roy B, Sengupta S. Emerging technologies for enabling proangiogenic therapy. Nanotechnology. 2011 Dec 09; 22(49):494004. PMID: 22101316.
    Citations: 3     Fields:    Translation:HumansAnimals
  37. Paraskar A, Soni S, Basu S, Amarasiriwardena CJ, Lupoli N, Srivats S, Roy RS, Sengupta S. Rationally engineered polymeric cisplatin nanoparticles for improved antitumor efficacy. Nanotechnology. 2011 Jul 01; 22(26):265101. PMID: 21576779.
    Citations: 8     Fields:    Translation:HumansAnimalsCells
  38. Sengupta P, Basu S, Sengupta S. Cancer, signal transduction and nanotechnology. Curr Drug Deliv. 2011 May; 8(3):254-60. PMID: 21291374.
    Citations:    Fields:    Translation:HumansAnimalsCells
  39. Banerjee D, Harfouche R, Sengupta S. Nanotechnology-mediated targeting of tumor angiogenesis. Vasc Cell. 2011 Jan 31; 3(1):3. PMID: 21349160.
    Citations: 10     
  40. Piecewicz S, Sengupta S. The dynamic glycome microenvironment and stem cell differentiation into vasculature. Stem Cells Dev. 2011 May; 20(5):749-58. PMID: 21091341.
    Citations: 1     Fields:    Translation:HumansAnimalsCells
  41. Banerjee D, Sengupta S. Nanoparticles in cancer chemotherapy. Prog Mol Biol Transl Sci. 2011; 104:489-507. PMID: 22093227.
    Citations: 5     Fields:    Translation:Humans
  42. Sinha Roy R, Soni S, Harfouche R, Vasudevan PR, Holmes O, de Jonge H, Rowe A, Paraskar A, Hentschel DM, Chirgadze D, Blundell TL, Gherardi E, Mashelkar RA, Sengupta S. Coupling growth-factor engineering with nanotechnology for therapeutic angiogenesis. Proc Natl Acad Sci U S A. 2010 Aug 03; 107(31):13608-13. PMID: 20639469.
    Citations: 7     Fields:    Translation:HumansAnimalsCells
  43. Paraskar AS, Soni S, Chin KT, Chaudhuri P, Muto KW, Berkowitz J, Handlogten MW, Alves NJ, Bilgicer B, Dinulescu DM, Mashelkar RA, Sengupta S. Harnessing structure-activity relationship to engineer a cisplatin nanoparticle for enhanced antitumor efficacy. Proc Natl Acad Sci U S A. 2010 Jul 13; 107(28):12435-40. PMID: 20616005.
    Citations: 27     Fields:    Translation:Animals
  44. Agarwal S, Dugar D, Sengupta S. Ranking chemical structures for drug discovery: a new machine learning approach. J Chem Inf Model. 2010 May 24; 50(5):716-31. PMID: 20387860.
    Citations: 13     Fields:    Translation:Cells
  45. Chaudhuri P, Harfouche R, Soni S, Hentschel DM, Sengupta S. Shape effect of carbon nanovectors on angiogenesis. ACS Nano. 2010 Jan 26; 4(1):574-82. PMID: 20043662.
    Citations: 7     Fields:    Translation:HumansAnimalsCells
  46. Chaudhuri P, Soni S, Sengupta S. Single-walled carbon nanotube-conjugated chemotherapy exhibits increased therapeutic index in melanoma. Nanotechnology. 2010 Jan 15; 21(2):025102. PMID: 19955607.
    Citations: 9     Fields:    Translation:AnimalsCells
  47. Basu S, Chaudhuri P, Sengupta S. Targeting oncogenic signaling pathways by exploiting nanotechnology. Cell Cycle. 2009 Nov 01; 8(21):3480-7. PMID: 19823014.
    Citations: 4     Fields:    Translation:HumansAnimalsCells
  48. Harfouche R, Hentschel DM, Piecewicz S, Basu S, Print C, Eavarone D, Kiziltepe T, Sasisekharan R, Sengupta S. Glycome and transcriptome regulation of vasculogenesis. Circulation. 2009 Nov 10; 120(19):1883-1892. PMID: 19858418.
    Citations: 7     Fields:    Translation:AnimalsCells
  49. Chaudhuri P, Paraskar A, Soni S, Mashelkar RA, Sengupta S. Fullerenol-cytotoxic conjugates for cancer chemotherapy. ACS Nano. 2009 Sep 22; 3(9):2505-14. PMID: 19681636.
    Citations: 17     Fields:    Translation:HumansAnimalsCells
  50. Basu S, Harfouche R, Soni S, Chimote G, Mashelkar RA, Sengupta S. Nanoparticle-mediated targeting of MAPK signaling predisposes tumor to chemotherapy. Proc Natl Acad Sci U S A. 2009 May 12; 106(19):7957-61. PMID: 19383798.
    Citations: 25     Fields:    Translation:HumansAnimalsCells
  51. Harfouche R, Basu S, Soni S, Hentschel DM, Mashelkar RA, Sengupta S. Nanoparticle-mediated targeting of phosphatidylinositol-3-kinase signaling inhibits angiogenesis. Angiogenesis. 2009; 12(4):325-38. PMID: 19685150.
    Citations: 16     Fields:    Translation:HumansAnimalsCells
  52. Sengupta S, Sasisekharan R. Exploiting nanotechnology to target cancer. Br J Cancer. 2007 May 07; 96(9):1315-9. PMID: 17406364.
    Citations: 8     Fields:    Translation:Humans
  53. Sengupta S, Chakrabarti S, Roy A, Panda CK, Roychoudhury S. Inactivation of human mutL homolog 1 and mutS homolog 2 genes in head and neck squamous cell carcinoma tumors and leukoplakia samples by promoter hypermethylation and its relation with microsatellite instability phenotype. Cancer. 2007 Feb 15; 109(4):703-12. PMID: 17219447.
    Citations: 11     Fields:    Translation:HumansCells
  54. Mondal G, Sengupta S, Panda CK, Gollin SM, Saunders WS, Roychoudhury S. Overexpression of Cdc20 leads to impairment of the spindle assembly checkpoint and aneuploidization in oral cancer. Carcinogenesis. 2007 Jan; 28(1):81-92. PMID: 16777988.
    Citations: 36     Fields:    Translation:HumansCells
  55. Chakrabarti S, Sengupta S, Sengupta A, Basak SN, Roy A, Panda C, Roychoudhury S. Genomic instabilities in squamous cell carcinoma of head and neck from the Indian population. Mol Carcinog. 2006 Apr; 45(4):270-7. PMID: 16402388.
    Citations: 2     Fields:    Translation:HumansCells
  56. Sengupta S, Eavarone D, Capila I, Zhao G, Watson N, Kiziltepe T, Sasisekharan R. Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system. Nature. 2005 Jul 28; 436(7050):568-72. PMID: 16049491.
    Citations: 153     Fields:    Translation:HumansAnimalsCells
  57. Sengupta S, Sellers LA, Gherardi E, Sasisekharan R, Fan TP. Nitric oxide modulates hepatocyte growth factor/scatter factor-induced angiogenesis. Angiogenesis. 2004; 7(4):285-94. PMID: 15886872.
    Citations: 3     Fields:    Translation:HumansAnimalsCells
  58. Sengupta S, Toh SA, Sellers LA, Skepper JN, Koolwijk P, Leung HW, Yeung HW, Wong RN, Sasisekharan R, Fan TP. Modulating angiogenesis: the yin and the yang in ginseng. Circulation. 2004 Sep 07; 110(10):1219-25. PMID: 15337705.
    Citations: 67     Fields:    Translation:HumansAnimalsCells
  59. Sengupta S, Kiziltepe T, Sasisekharan R. A dual-color fluorescence imaging-based system for the dissection of antiangiogenic and chemotherapeutic activity of molecules. FASEB J. 2004 Oct; 18(13):1565-7. PMID: 15333517.
    Citations: 2     Fields:    Translation:HumansCells
  60. Qi Y, Zhao G, Liu D, Shriver Z, Sundaram M, Sengupta S, Venkataraman G, Langer R, Sasisekharan R. Delivery of therapeutic levels of heparin and low-molecular-weight heparin through a pulmonary route. Proc Natl Acad Sci U S A. 2004 Jun 29; 101(26):9867-72. PMID: 15226520.
    Citations: 13     Fields:    Translation:AnimalsCells
  61. Sengupta S, Sellers LA, Cindrova T, Skepper J, Gherardi E, Sasisekharan R, Fan TP. Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesis. Cancer Res. 2003 Dec 01; 63(23):8351-9. PMID: 14678996.
    Citations: 4     Fields:    Translation:HumansAnimalsCells
  62. Johnson NA, Sengupta S, Saidi SA, Lessan K, Charnock-Jones SD, Scott L, Stephens R, Freeman TC, Tom BD, Harris M, Denyer G, Sundaram M, Sasisekharan R, Smith SK, Print CG. Endothelial cells preparing to die by apoptosis initiate a program of transcriptome and glycome regulation. FASEB J. 2004 Jan; 18(1):188-90. PMID: 14630703.
    Citations: 9     Fields:    Translation:HumansCells
  63. Sengupta S, Sellers LA, Li RC, Gherardi E, Zhao G, Watson N, Sasisekharan R, Fan TP. Targeting of mitogen-activated protein kinases and phosphatidylinositol 3 kinase inhibits hepatocyte growth factor/scatter factor-induced angiogenesis. Circulation. 2003 Jun 17; 107(23):2955-61. PMID: 12782568.
    Citations: 5     Fields:    Translation:HumansAnimalsCells
  64. Sengupta S, Sellers LA, Matheson HB, Fan TP. Thymidine phosphorylase induces angiogenesis in vivo and in vitro: an evaluation of possible mechanisms. Br J Pharmacol. 2003 May; 139(2):219-31. PMID: 12770927.
    Citations: 12     Fields:    Translation:HumansAnimalsCells
  65. Sengupta S, Gherardi E, Sellers LA, Wood JM, Sasisekharan R, Fan TP. Hepatocyte growth factor/scatter factor can induce angiogenesis independently of vascular endothelial growth factor. Arterioscler Thromb Vasc Biol. 2003 Jan 01; 23(1):69-75. PMID: 12524227.
    Citations: 31     Fields:    Translation:HumansAnimalsCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Sengupta's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (369)
Explore
_
Co-Authors (18)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.